The patient-based analysis identified one additional significant gene, ZNF845 (Padj = 2.6 × 10−2), whereas the tumor-based analysis identified four, TNRC6B (Padj = 2.9 × 10−4), ZNF780B (Padj = 4.2 × 10−2), RPP30 (Padj = 6.4 × 10−2), and CASQ1 (Padj = 8.7 × 10−2). Here, CASQ1 is linked to neoplasm.